59 related articles for article (PubMed ID: 18274744)
1. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer.
Lynch MA; Jackson J; Kim JA; Leeming RA
Surgery; 2008 Oct; 144(4):525-31; discussion 531-2. PubMed ID: 18847635
[TBL] [Abstract][Full Text] [Related]
2. Subareolar versus peritumoral injection for location of the sentinel lymph node.
Klimberg VS; Rubio IT; Henry R; Cowan C; Colvert M; Korourian S
Ann Surg; 1999 Jun; 229(6):860-4; discussion 864-5. PubMed ID: 10363900
[TBL] [Abstract][Full Text] [Related]
3. Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience.
Santana Valenciano Á; Rivas Fidalgo S; Corral Moreno S; Gamero Medina V; Martín Blanco C; Pérez Izquierdo CB; Mena Mateos A; Cabañas Montero J; Fernández Cebrián JM
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38806876
[TBL] [Abstract][Full Text] [Related]
4. Sonographic Features of Palpable Breast and Axillary Lesions in Adult Male Patients: A Pictorial Essay.
Jung HK; Lim YJ
J Korean Soc Radiol; 2022 Jul; 83(4):830-845. PubMed ID: 36238906
[TBL] [Abstract][Full Text] [Related]
5. Unknown Case: Palpable Mass in the Axilla.
Reya N; Yang M
J Breast Imaging; 2024 May; 6(3):327-329. PubMed ID: 38447225
[No Abstract] [Full Text] [Related]
6. Value of sentinel lymph node biopsy in breast cancer patients with previous excisional biopsy.
Coskun G; Dogan L; Karaman N; Ozaslan C; Atalay C
J Breast Cancer; 2012 Mar; 15(1):87-90. PubMed ID: 22493633
[TBL] [Abstract][Full Text] [Related]
7. Current status of sentinel lymph-node biopsy in patients with breast cancer.
Cheng G; Kurita S; Torigian DA; Alavi A
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):562-75. PubMed ID: 20700739
[TBL] [Abstract][Full Text] [Related]
8. The sentinel node in breast cancer.
Collins CD
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S10-8. PubMed ID: 18852076
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique.
Newman LA
J Am Coll Surg; 2004 Nov; 199(5):804-16. PubMed ID: 15501123
[No Abstract] [Full Text] [Related]
10. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
11. Staging the axilla with selective sentinel node biopsy in patients with previous excision of non-palpable and palpable breast cancer.
Ruano R; Ramos M; Garcia-Talavera JR; Serrano E; De Arriba A; Gonzalez-Orus J; Iglesias M; Macias MC
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1299-304. PubMed ID: 18274744
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer.
Olson JA; Fey J; Winawer J; Borgen PI; Cody HS; Van Zee KJ; Petrek J; Heerdt AS
J Am Coll Surg; 2000 Dec; 191(6):593-9. PubMed ID: 11129806
[TBL] [Abstract][Full Text] [Related]
14. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
